ISRCTN50678517已完成不适用
A randomised phase III study for the treatment of recurrent epithelial ovarian cancer: chemotherapy alone versus chemotherapy followed by secondary cytoreductive surgery in patients with a disease-free interval of more than 6 months
Erasmus Medical Centre (The Netherlands)0 个研究点目标入组 700 人开始时间: 2005年12月20日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 700
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Recurrence of epithelial ovarian cancer
- •2. After first line chemotherapy with a disease-free interval of at least 6 months
- •3. Aged greater than 18 years
- •4. World Health Organization (WHO) Performance Status 0 - 2
- •5. First-line therapy should have consisted of at least four courses of either cisplatin or carboplatin
排除标准
- •1. More than one line chemotherapy
- •2. Complete bowel obstruction
- •3. Metastasised carcinoma (other tumour)
- •4. Leptomeningeal or brain metastases
研究者
相似试验
招募中
3 期
Phase III randomised trial evaluating chemotherapy early treatment intensification with temozolomide in adults present with a glioblastoma2022-500451-23-00Centre Oscar Lambret400
进行中（未招募）
1 期
Phase III randomised, placebo controlled study of sorafenib in repeated cycles of 21 days in combination with paclitaxel/carboplatin chemotherapy in subjects with unresectable stage III or stage IV melanomaEUCTR2005-000941-12-GBOnyx Pharmaceuticals, Inc.
已完成
3 期
ISG/AIEOP EW-1: Randomised controlled trial for patients with non-metastatic Ewing sarcomaCancerISRCTN50580483Italian Sarcoma Group (Italy)220
进行中（未招募）
1 期
EMT2: EPA for Metastasis TrialColorectal cancer liver metastasesMedDRA version: 20.0Level: LLTClassification code 10007095Term: Cancer of liver, secondarySystem Organ Class: 100000004864EUCTR2016-000628-24-GBniversity of Leeds448
进行中（未招募）
1 期
A randomised Phase III trial to evaluate the efficacy of chemoimmunotherapy with the monoclonal antibody Campath-1H (Alemtuzumab) given in combination with 2-weekly CHOP (Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) versus 2-weekly CHOP alone in elderly patients with previously untreated systemic T- cell Lymphoma Short Title: A-CHOP-14 (elderly) - A-CHOP-14 (elderly)Primary therapy of patients with Alk-negative T-NHL in patients aged 61 - 80 yearsICD classification codes : ICD-O 9702/39717/39716/39708/39705/39714/3MedDRA version: 9.1Level: LLTClassification code 10002464Term: Angiomimmunoblastic (AILD, LgX (Kiel Classification)MedDRA version: 9.1Level: LLTClassification code 10025632Term: Malignant lymphomaEUCTR2007-000821-23-BEniversity Medicine Goettingen274